In 2019, Eli Lillyreleasedthe first generic insulin,insulin lispro. It is the counterpart toHumalog, a popular rapid-acting insulin. Since then, the FDA has approved generic versions ofHumalog 75/25(insulin lispro 75/25),Novolog(insulin aspart),Novolog 70/30(insulin aspart 70/30), andLantus...